发明名称 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen
摘要 The present patent application relates to 11beta-benzaldoxime derivatives of D-homooestra-4,9-dien-3-ones of formula I: wherein R1 is a hydrogen atom or a C1-C6-alkyl, C1-C6-acyl, C1-C4-alkoxycarbonyl, C1-C4-alkylthiocarbonyl, C1-C6-alkylaminocarbonyl or arylaminocarbonyl group; and R2 is a hydrogen atom or a C1-C6-alkyl or C1-C6-acyl group. Compounds of formula I bind more strongly to the glucocorticoid receptor than to the progesterone receptor and are effective antiglucocorticoids. According to the invention, they are suitable for the treatment and/or prevention of symptoms and/or diseases that are attributable to an androgen deficiency induced by glucocorticoids, especially cortisol.
申请公布号 DE102005059222(B4) 申请公布日期 2007.10.11
申请号 DE20051059222 申请日期 2005.12.08
申请人 BAYER SCHERING PHARMA AG 发明人 RING, SVEN;SCHUBERT, GERD;SOBEK, LOTHAR
分类号 C07J53/00;A61K31/56;A61P5/26;C07J1/00 主分类号 C07J53/00
代理机构 代理人
主权项
地址